Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

MRI may help tailor breast cancer chemo early

NCT ID NCT00462696

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study looked at whether MRI scans can detect how well breast cancer responds to chemotherapy early in treatment. Sixteen women with invasive breast cancer received standard chemo before surgery, and their MRI results were checked by two radiologists. The goal was to see if MRI measurements are reliable enough to guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institut Bergonie

    Bordeaux, 33076, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

epirubicin and docetaxel (chemotherapy)

What this could lead to

If MRI proves reliable, it could help doctors adjust chemotherapy early for better outcomes.

What could go wrong

This is a very small, early study (16 people) focused on imaging reproducibility, not on treatment success or survival.

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.